Cargando…
Efficacy, safety, and retention rate of extended-release divalproex versus conventional delayed-release divalproex: A protocol for systematic review and meta-analysis
BACKGROUND: A novel once-daily divalproex-extended release (VPA-ER) dose formulation has been developed, which prolongs therapeutic serum levels compared with that of twice-daily conventional divalproex-delayed release (VPA-DR). Currently, there is lack of meta-analysis focusing on drug retention ra...
Autores principales: | Zhang, Chen Qi, Bai, Xue Yang, Wan, Yong, Li, Hong Yan, Sun, Hongbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678006/ https://www.ncbi.nlm.nih.gov/pubmed/34918705 http://dx.doi.org/10.1097/MD.0000000000028290 |
Ejemplares similares
-
Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials
por: Zhang, Chen Qi, et al.
Publicado: (2022) -
Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
por: Stoner, Steven C, et al.
Publicado: (2007) -
Release property study on the novel divalproex sodium enteric-coated capsules
por: Yang, Shuoye, et al.
Publicado: (2016) -
Divalproex sodium in severe anaemia: A case report
por: Gupta, Maneesh
Publicado: (2007) -
Suicidality and divalproex sodium: analysis of controlled studies in multiple indications
por: Redden, Laura, et al.
Publicado: (2011)